An Open-Label, 2-Period Sequential Drug Interaction Study to Evaluate the Effect of a 100 Mg Dose of Desvenlafaxine SR on the Pharmacokinetics of Tamoxifen When Co-administered in Healthy Post-menopausal Female Subjects.
Phase of Trial: Phase IV
Latest Information Update: 20 Aug 2014
At a glance
- Drugs Desvenlafaxine; Tamoxifen
- Indications Breast cancer; Depressive disorders
- Focus Pharmacokinetics
- Sponsors Pfizer
- 09 Sep 2011 Last checked against ClinicalTrials.gov record.
- 23 Nov 2010 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 23 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.